Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2007
10/31/2007CN101062407A Function of erythropoietin in the preventing and treating of retinal injury
10/31/2007CN101062406A Reeombinnt human granulocyte colony stimulating factor microemulsion
10/31/2007CN101062405A Medicine for animals for treating and preventing avian influenza
10/31/2007CN101062404A Pidotimod injection and the producing method thereof
10/31/2007CN101062403A Process for preparing bone peptide injection
10/31/2007CN101062059A Method for preparing jumbuck thymosin
10/31/2007CN101062009A Therapeutikum mit einem botulinum-neurotoxin
10/31/2007CN100345970C Receptor based antagonists and mehtods of making and using
10/31/2007CN100345866C Compound for unstable dipeptidyl peptidase IV inhibitors
10/31/2007CN100345865C Antibiotic dipeptide and its chemical modifier, its preparation method and uses
10/31/2007CN100345596C medicinal aerosol formulation
10/31/2007CN100345591C Instant freeze-dried fibriogen preparation with anti dry heat treatment
10/31/2007CN100345590C Lozenge containing liver cell growth promoting agent and interferon
10/31/2007CN100345589C Essential element nutritive preparation for intestine
10/31/2007CN100345552C Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/31/2007CN100345547C Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations
10/31/2007CN100345541C Microcapsules for the delayed, controlled release of perindopril
10/31/2007CN100345535C The Controlled release preparation of insulin and its method
10/31/2007CN100345528C Insert for the treatment of dry eye
10/30/2007US7288646 USPA2 nucleic acid of Moraxella catarrhalis
10/30/2007US7288644 Cellular genes regulated by HIV-1 infection and methods of use thereof
10/30/2007US7288633 To induce the activities of B cells and T cells in therapy of immune deficiency disorders, viral infections, and bacterial infections
10/30/2007US7288631 G-coupled receptor showing selective affinity for ATP
10/30/2007US7288630 Potassium channel KCNQ5 and sequences encoding the same
10/30/2007US7288629 Pro9925 polypeptides
10/30/2007US7288628 PRO20088 polypeptides
10/30/2007US7288627 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for releasing tumor necrosis factor from blood; for modulating uptake of glucose by skeletal muscle cells; for stimulating release of proteoglycans from cartilage
10/30/2007US7288626 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/30/2007US7288625 PRO4395 polypeptides
10/30/2007US7288624 Treating IL-1 mediated disease, autoimmune disease, inflammatory disease and neurodegenerative disease with ICE inhibitors characterized by specific structural and physicochemical features.
10/30/2007US7288623 Cyclic peptide tube
10/30/2007US7288621 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
10/30/2007US7288559 Carboxamide spirohydantoin CGRP receptor antagonists
10/30/2007US7288530 Cancer therapy
10/30/2007US7288527 Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester
10/30/2007US7288526 Antiinflammatory agents
10/30/2007US7288525 Method for lowering serum homocysteine
10/30/2007US7288523 for the treatment of prevention of Alzheimer disease associated with amyloidosis
10/30/2007US7288522 Method of promoting erythropoiesis
10/30/2007US7288521 Growth factor therapy mobilization of stem cells into the peripheral blood
10/30/2007US7288520 Cyclosporin compositions
10/30/2007US7288519 Exocyclic peptide having amino acid sequence of a Fas surface domain; antagonists of the Fas receptor (Fas)-Fas ligand complex
10/30/2007US7288517 Especially treating Alzheimer's disease with cetrorelix.
10/30/2007US7288516 Null IGF for the treatment of cancer
10/30/2007US7288406 Antitumor agents; wound healing agents; muscular disorders
10/30/2007US7288400 Nucleic acids encoding esterases and methods of making and using them
10/30/2007US7288398 Molecules
10/30/2007US7288392 Vectors, host cells, and recombinant methods for making and using the novel molecules
10/30/2007US7288390 Anti-dual integrin antibodies, compositions, methods and uses
10/30/2007US7288385 Identifying a compound that modulates the insulin/IGF-I pathway by contacting a that expresses a Smek protein with a compound, and comparing the activity of the Smek protein after contacting and the activity of the Smek protein in the absence of the compound; the compounds increase stress tolerance
10/30/2007US7288375 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution
10/30/2007US7288267 Bioadhesive nanoparticulate compositions having cationic surface stabilizers
10/30/2007US7288260 Using botulinun toxin to treat pain for sustained release
10/30/2007US7288259 Administering botulinum toxin to the patient, wherein excess levels of glandular secretion result in the conditions which are selected from seborrheic dermatitis, rhinophyma, seborrhea, seborrheic blepharitis and sebaceous cysts, whereby the excess levels of glandular secretions is reduced
10/30/2007US7288258 Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination
10/30/2007US7288257 Using 3,3',5'-triiodothyronine concentration for detecting fibromyalgia, autoimmune, coronary artery, cancer and alzheimer's diseases
10/30/2007US7288256 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
10/30/2007US7288254 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
10/30/2007US7288249 Antibodies for cancer therapy and diagnosis
10/30/2007US7288246 Method of alleviating chronic pain via peripheral glutaminase regulation
10/30/2007US7288243 Aerosol drug inhibition of lung metastases
10/30/2007CA2451433C Oligopeptide transporter 1 inhibitor
10/30/2007CA2297083C Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections
10/30/2007CA2288948C Modified arginine deiminase
10/30/2007CA2274512C Biological pesticide
10/30/2007CA2272356C Soluble polypeptides
10/30/2007CA2261564C Parathyroid hormone analogues for the treatment of osteoporosis
10/30/2007CA2220012C Methods for modulating t cell survival by modulating bcl-xl protein level
10/30/2007CA2186760C Use of biopolymers for the muscle treatment
10/30/2007CA2186757C Use of biopolymers for digestive tract injuries treatment
10/30/2007CA2184920C Methods of diagnosing and treating preeclampsia
10/30/2007CA2183577C Methods and compositions for pulmonary delivery of insulin
10/30/2007CA2164291C Methods and pharmaceutical compositions useful for treating neurological disorders
10/30/2007CA2161350C Oxygen-reduced aqueous solution of factor viii
10/30/2007CA2142007C Immunomodulatory peptides
10/30/2007CA2105101C The use of the il-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections
10/30/2007CA2091663C Cyclic peptide antifungal agents and process for preparation thereof
10/25/2007WO2007121318A2 Formulations for delivering insulin
10/25/2007WO2007121256A2 Rapid acting and long acting insulin combination formulations
10/25/2007WO2007121233A1 Methods of treating autoimmune diseases
10/25/2007WO2007121125A2 Hcv inhibitors
10/25/2007WO2007121124A2 Hcv inhibitors comprising beta amino acids and their uses
10/25/2007WO2007120899A2 Pharmaceutical compositions of hglp-1, exendin-4 and analogs thereof
10/25/2007WO2007120847A2 Identifying and modulating molecular pathways that mediate nervous system plasticity
10/25/2007WO2007120815A2 Methods for treating lymphocyte-associated disorders by modulation of siglec activity
10/25/2007WO2007120648A2 Mono and di-substituted oxycodone compounds and compositions
10/25/2007WO2007120504A2 Targeted charge-reversal nanoparticles for nuclear drug delivery
10/25/2007WO2007120457A2 Composition and method for stabilizing corneal tissue after refractive surgery
10/25/2007WO2007120151A1 Novel enterococcus and streptococcus strains and bacteriocins
10/25/2007WO2007119787A1 Phosphatase involved in the regulation of cardiomyocyte differentiation
10/25/2007WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof
10/25/2007WO2007119590A1 Wheat-derived anti-hypertensive composition
10/25/2007WO2007119515A1 Novel tumor antigen peptides
10/25/2007WO2007119503A1 Wake-up remedy
10/25/2007WO2007119502A1 Bowel movement remedy
10/25/2007WO2007119486A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer
10/25/2007WO2007119214A2 Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
10/25/2007WO2007119201A2 Novel antibacterial compounds
10/25/2007WO2007118901A2 Tracheal cytotoxin (tct) and related compounds for suppressing immune responses
10/25/2007WO2007118889A1 Specific protease for inactivation of human tumour necrosis factor-alpha
1 ... 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 ... 3163